Adam Colborn

3 weeks ago | ajmc.com | Pearl Steinzor |Adam Colborn

The Ensuring Community Access to Pharmacist Services (ECAPS) Act of 2025 is a bipartisan bill that would ensure that Americans continue to have reliable access to testing and treatment for respiratory illnesses, including COVID-19, respiratory syncytial virus (RSV), the flu, and other potential future threats to public health, Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP), explained.

2 months ago | ajmc.com | Pearl Steinzor |Adam Colborn

In a comprehensive policy update, Adam Colborn, JD, associate vice president for congressional affairs at the Academy of Managed Care Pharmacy (AMCP), highlighta a wave of over 500 state-level bills poised to have an impact on managed care pharmacy. Central themes include reforms targeting pharmacy benefit managers (PBMs) and 340B hospitals—both under increasing scrutiny for their roles in drug pricing. He also discusses the Medicaid VBPs for Patients (MVP) Act (H.R. 2666/S.

2 months ago | ajmc.com | Pearl Steinzor |Susan A. Cantrell |Adam Colborn |Neha Kashalikar |Sam Peasah

The Academy of Managed Care Pharmacy (AMCP) conference is highly valued for fostering a sense of community and strategic thinking among managed care pharmacy professionals.

2 months ago | ajmc.com | Pearl Steinzor |Adam Colborn

Liability for artificial intelligence (AI) in managed care pharmacy may follow the current provider-side model, but the situation could evolve, says Adam Colburn, JD, vice president for congressional affairs at the Academy of Managed Care Pharmacy (AMCP). This transcript was lightly edited; captions were auto-generated. TranscriptWhat are the key regulatory considerations managed care pharmacists should be aware of when implementing AI tools?